News Headlines Article

Survival time increases for those with deadly brain cancer: Study
San Diego Union-Tribune

Despite all the medical advances against cancer, the outlook is poor for patients with high-grade glioma. This especially deadly form of brain cancer involves aggressive tumors that often infiltrate healthy tissue.

Surgery, radiation and chemotherapy may control the disease for a short while, but the cancer soon regrows. The average survival time for these patients is measured in months. A cure isn’t in sight.

But experimental treatments now undergoing testing hold the promise of keeping gliomas at bay, perhaps for years. The latest sign of hope came Wednesday from an early stage clinical trial of a therapy by San Diego’s Tocagen. The treatment turns cancer’s deadliest weapon, its ability to grow rapidly, against itself.